Bookings Holdings Inc. (NASDAQ:BKNG) Bank of America Securities 2025 Global Technology Conference June 4, 2025 2:20 PM ET Company Participants Ewout Lucien Steenbergen - Executive VP & CFO Conference Call Participants Justin Post - BofA Securities, Research Division Justin Post Thank you, everyone, for joining us. We are very happy to have Ewout Steenbergen, did I pronounce it right, I hope, for a little Q&A with Booking. Covered Booking, used to be Priceline for 18 years and have always appreciated the com ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises NET Power Inc. ("NET Power " or the "Company") (NYSE: NPWR; NPWR WS) investors of a class action representing investors that bought securities between June 9, 2023 and March 7, 2025, inclusive (the "Class Period"). NET Power investors have until June 17, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F ...

TORONTO, June 4, 2025 /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the "Company" or "Sun Life") announced today that the Office of the Superintendent of Financial Institutions and the Toronto Stock Exchange (the "TSX") have approved the Company's previously announced early renewal of its normal course issuer bid.As of the date hereof, the Company has purchased on the TSX, other Canadian stock exchanges and/or alternative Canadian trading platforms 14,429,085 of the 15,000,000 common shares ...

Core Insights - The ongoing 618 shopping festival in China is showing strong performance, positively impacting Alibaba's stock, which rose nearly 4% [1] - Preliminary data indicates a significant increase in sales during the 618 period, with Alibaba's Taobao and Tmall Group reporting a 283% rise in government-subsidized categories compared to the previous year's Singles' Day [4] - JD.com also reported impressive sales, with a 380% year-over-year surge in home appliances and electronics within the first hour of its 618 campaign [5] Company Performance - Alibaba's stock performance is benefiting from the lively shopping activity during the 618 festival, contrasting with the flat performance of the S&P 500 [1] - The company's internal data suggests a robust shopping environment, which is likely to enhance its market position [1][4] Industry Trends - The 618 shopping festival, initiated by JD.com, has become a significant event for various Chinese retailers, including Alibaba, offering extensive deals and discounts [2] - The Chinese government's subsidy program is playing a crucial role in boosting sales, particularly in home appliances and related products, indicating a trend that could benefit multiple online retailers [6][7]

Core Viewpoint - Zenas BioPharma is facing a class action lawsuit due to allegations of misleading information in its IPO registration statement, which has resulted in significant financial losses for investors [1][3][4]. Group 1: Company Overview - Zenas BioPharma is a clinical-stage biopharmaceutical company focused on developing and commercializing immunology-based therapies [3]. Group 2: IPO Details - The company sold over 13 million shares at a price of $17.00 each during its IPO [3]. - The IPO registration statement claimed that Zenas BioPharma could fund its operations for 24 months using existing cash and anticipated IPO proceeds [3]. Group 3: Allegations and Financial Impact - The class action lawsuit alleges that the IPO documents were materially false and misleading, particularly regarding the funding timeline [3]. - On November 12, 2024, Zenas BioPharma disclosed in its quarterly report that it could only fund operations for 12 months, contradicting the earlier statement [4]. - As of April 15, 2025, the stock price had dropped to $8.72, representing a decline of 48.7% from the IPO price [4].

Dynavax is Already Delivering Significant Long Term Stockholder Value Through Execution of Current Strategy Overseen by Board; Deep Track's Inferior Short-Term Plan and Nominees are Not in the Best Interests of All Stockholders Glass Lewis' Recommendation Recognizes the Significant Stockholder Value Creation and Differentiated Capital Return Overseen by the Dynavax BoardReiterates ISS and Egan Jones Recommendations that Stockholders Support ALL Dynavax Nominees and Deep Track Board Representation is Not War ...

Core Viewpoint - Ibotta, Inc. is facing a class action lawsuit due to alleged misleading statements in its registration statement related to its IPO on April 18, 2024, particularly concerning its contract with Kroger [1][3][4] Group 1: Legal Action - The Portnoy Law Firm is advising Ibotta investors about a class action lawsuit for those who purchased securities linked to the company's IPO [1] - Investors have until June 16, 2025, to file a lead plaintiff motion [1] Group 2: Allegations - The complaint claims that the registration statement failed to disclose the at-will nature of Ibotta's contract with Kroger, which could be terminated at any time without notice [3] - The registration statement provided details about Ibotta's contract with Walmart but omitted warnings regarding the risks associated with the Kroger agreement [3] Group 3: Financial Impact - Due to the alleged wrongful acts and omissions, Ibotta's stock price experienced a sharp decline, resulting in substantial losses for the plaintiff and other class members [4]

ATLANTA, June 04, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) complied with federal securities laws. On June 4, 2025, Morpheus Research published a report alleging that Abacus’s returns “are primarily manufactured by the systematic overvaluation of its assets through an opaque ‘mark to model’ accounting scheme that closely mirrors past blow-ups in the life settlements industry.” Following this report, the pri ...

HealthEquity, Inc. HQY posted better-than-expected first-quarter results after Tuesday’s closing bell.HealthEquity reported quarterly earnings of 97 cents per share, which beat the consensus estimate of 88 cents. Quarterly revenue came in at $330.8 million, beating the Street estimate of $321.17 million."The HealthEquity team started fiscal 2026 with a strong first quarter that included record quarterly revenue, record Adjusted EBITDA and increased guidance for the year," said Scott Cutler, CEO of HealthEqu ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BigBear.ai Holdings, Inc. ("BigBear " or the "Company") (NYSE: BBAI) investors of a class action representing investors that bought securities between March 31, 2022 and March 25, 2025, inclusive (the "Class Period"). BigBear investors have until June 10, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley ...